JP2019527708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527708A5 JP2019527708A5 JP2019506673A JP2019506673A JP2019527708A5 JP 2019527708 A5 JP2019527708 A5 JP 2019527708A5 JP 2019506673 A JP2019506673 A JP 2019506673A JP 2019506673 A JP2019506673 A JP 2019506673A JP 2019527708 A5 JP2019527708 A5 JP 2019527708A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- crystal
- compound represented
- phosphate
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610665625.9 | 2016-08-12 | ||
| CN201610666564 | 2016-08-12 | ||
| CN201610665625 | 2016-08-12 | ||
| CN201610666564.8 | 2016-08-12 | ||
| PCT/CN2017/097046 WO2018028666A1 (zh) | 2016-08-12 | 2017-08-11 | Dpp-iv长效抑制剂的结晶及其盐 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527708A JP2019527708A (ja) | 2019-10-03 |
| JP2019527708A5 true JP2019527708A5 (enExample) | 2020-09-24 |
| JP6997760B2 JP6997760B2 (ja) | 2022-01-18 |
Family
ID=61162770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019506673A Expired - Fee Related JP6997760B2 (ja) | 2016-08-12 | 2017-08-11 | Ｄｐｐ－ｉｖ長時間作用型阻害剤の結晶及びその塩 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10822319B2 (enExample) |
| EP (1) | EP3498704A4 (enExample) |
| JP (1) | JP6997760B2 (enExample) |
| KR (1) | KR20190039754A (enExample) |
| CN (1) | CN109874304B (enExample) |
| AU (1) | AU2017308691B2 (enExample) |
| CA (1) | CA3033890A1 (enExample) |
| RU (1) | RU2753335C9 (enExample) |
| WO (1) | WO2018028666A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108456196A (zh) * | 2017-02-22 | 2018-08-28 | 四川科伦博泰生物医药股份有限公司 | 3-氨基四氢吡喃衍生物的盐及其多晶型、其制备方法和用途 |
| CN111793071B (zh) * | 2020-07-06 | 2021-06-04 | 四川凯科医药科技有限公司 | 奥格列汀的合成工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001041016A2 (en) * | 1999-12-02 | 2001-06-07 | General Electric Company | System and method for valuing loan portfolios using fuzzy clustering |
| CA2640924C (en) * | 2006-02-15 | 2013-10-08 | Merck & Co., Inc. | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| JO2870B1 (en) * | 2008-11-13 | 2015-03-15 | ميرك شارب اند دوهم كورب | Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes |
| TWI574965B (zh) * | 2011-06-29 | 2017-03-21 | 默沙東藥廠 | 二肽基肽酶－ｉｖ抑制劑之新穎結晶型 |
| US9937153B2 (en) * | 2013-08-30 | 2018-04-10 | Merck Sharp & Dohme Ltd. | Oral pharmaceutical formulation of omarigliptin |
| CN105985357A (zh) * | 2015-02-12 | 2016-10-05 | 北京赛林泰医药技术有限公司 | 取代的氨基六元饱和杂脂环类长效dpp-iv抑制剂 |
| WO2017031918A1 (zh) | 2015-08-24 | 2017-03-02 | 四川科伦药物研究院有限公司 | 长效二肽基肽酶-iv抑制剂、用途及其中间体的制备方法 |
-
2017
- 2017-08-11 AU AU2017308691A patent/AU2017308691B2/en not_active Expired - Fee Related
- 2017-08-11 EP EP17838796.5A patent/EP3498704A4/en not_active Withdrawn
- 2017-08-11 RU RU2019105352A patent/RU2753335C9/ru active
- 2017-08-11 JP JP2019506673A patent/JP6997760B2/ja not_active Expired - Fee Related
- 2017-08-11 US US16/324,884 patent/US10822319B2/en active Active
- 2017-08-11 WO PCT/CN2017/097046 patent/WO2018028666A1/zh not_active Ceased
- 2017-08-11 CN CN201780044045.0A patent/CN109874304B/zh active Active
- 2017-08-11 CA CA3033890A patent/CA3033890A1/en not_active Abandoned
- 2017-08-11 KR KR1020197006819A patent/KR20190039754A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530565A5 (enExample) | ||
| JP2024026550A5 (enExample) | ||
| JP6483674B2 (ja) | ５−ブロモ−２−（α−ヒドロキシペンチル）安息香酸ナトリウム塩の複数の異なる結晶型及びそれらの調製方法 | |
| JP2021530456A5 (enExample) | ||
| JP2018531280A5 (enExample) | ||
| JP2015512942A5 (enExample) | ||
| RU2016123382A (ru) | Твердые формы { [5-(3-хлорфенил)-3-гидроксипиридин-2-карбонил]амино} уксусной кислоты, их композиции и применения | |
| JP2020519654A5 (enExample) | ||
| BR112020007826A2 (pt) | derivado de 4-benzopiranona, composição farmacêutica, composição alimentar funcional, método para tratamento de doenças relacionadas ao tnf, composição de reagente, método para inibir uma atividade de tnf | |
| JP2019525899A5 (enExample) | ||
| JP2012523395A5 (enExample) | ||
| JP2021501151A5 (enExample) | ||
| JP2019142893A5 (enExample) | ||
| KR102711647B1 (ko) | 신규한 tnf 활성 억제제 화합물 및 이의 약학적으로 허용가능한 염 | |
| JP2022523368A5 (enExample) | ||
| JP2016503752A5 (enExample) | ||
| JP2019516749A5 (enExample) | ||
| JP2019527708A5 (enExample) | ||
| HRP20251307T1 (hr) | Kristalni oblik trietilentetramin tetrahidroklorida i njegova farmaceutska upotreba | |
| JP2016510768A5 (enExample) | ||
| RU2015130602A (ru) | Соли и кристаллические формы | |
| JP2016537326A5 (enExample) | ||
| RU2019105352A (ru) | Кристалл ингибитора DPP-IV длительного действия и его соли | |
| CN111989329A (zh) | 氘代3-(4,5-取代氨基嘧啶)苯基化合物单甲磺酸盐晶型及其制备方法 | |
| JP2018522945A5 (enExample) |